[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100623848":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":20,"locations":27,"responsibleParty":47,"collaborators":10,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":10,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Hopitaux de Saint-Maurice","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Pediatric limb amputation cohort",null,"This cohort includes children and adolescents aged 5 to 18 years who underwent limb amputation during childhood and are followed at a specialized pediatric limb anomaly referral center.\n\nParticipants are evaluated at a single time point using retrospective medical record data and standardized questionnaires administered during routine follow-up visits, without any modification of standard clinical care.",[13,17],{"name":14,"affiliation":15,"role":16},"Margaux MM Modjbafan","Hôpitaux Paris Est Val-de-Marne, centre de référence des malformations des membres, Saint-Maurice 94410","PRINCIPAL_INVESTIGATOR",{"name":18,"affiliation":15,"role":19},"Maïwenn MF Feldmann","STUDY_DIRECTOR",[21],{"name":22,"role":23,"phone":24,"phoneExt":25,"email":26},"Auriane AS SLAMA","CONTACT","+33143967556","+33607317969","auriane.slama@ght94n.fr",[28],{"facility":29,"status":30,"city":31,"state":10,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Hôpitaux Paris Est Val-de-Marne - Centre de Référence des Malformations des Membres","RECRUITING","Saint-Maurice","94410","France","FR",{"type":36,"coordinates":37},"Point",[38,39],2.42716,48.82182,{"lat":39,"lon":38},[42,45],{"name":14,"role":23,"phone":43,"phoneExt":10,"email":44},"+33143966643","margaux.modjbafan@ght94n.fr",{"name":18,"role":23,"phone":43,"phoneExt":10,"email":46},"maiwenn.feldmann@ght94n.fr",{"type":48,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100623848","amputations-in-childhood-and-neuropathic-pain-100623848",false,"NCT07401966","Amputations in Childhood and Neuropathic Pain","NAPE","Inclusion Criteria:\n\n* Patients aged between 5 and 18 years (inclusive) (Piaget's concrete operational stage to be able to complete the self-assessment questionnaires)\n* Patients who underwent amputation before the age of 15 for girls and 16 for boys (average age of completion of lower limb growth)\n* Patients who have not undergone surgery on the amputated limb for at least one year (to avoid bias, as any surgery involving incision can cause temporary neuropathic pain unrelated to the amputation)\n* Have obtained the signature of the non-objection form by both parents\u002Flegal guardians\n* Have obtained the child's consent (verbal consent but recorded)\n* Be affiliated with a health insurance plan.\n\nExclusion Criteria:\n\n* Patients who do not speak French\n* Patients whose cognitive abilities are insufficient (as determined by a clinician or reported by parents) to be able to complete self-assessment questionnaires\n* Patients undergoing chemotherapy (due to transient neuropathic pain)\n* Patients who have received chemotherapy and whose side effects have not yet subsided (on a case-by-case basis depending on the chemotherapy used)\n* Patients who have received chemotherapy causing neuropathic pain due to this treatment that has not disappeared.\n* Patients placed under protective custody.","ALL","5 Years","18 Years",{"count":60,"type":61},50,"ESTIMATED","OBSERVATIONAL","This observational study aims to assess the presence of neuropathic pain in children and adolescents who underwent limb amputation during childhood.\n\nThe study focuses on two types of neuropathic pain: phantom limb pain and residual limb pain. It also evaluates quality of life and functional autonomy in this population and explores potential associations between neuropathic pain, autonomy, quality of life, and age at amputation.\n\nUsing a mixed retrospective and prospective design, data are collected from medical records and standardized questionnaires administered during routine follow-up visits at a specialized pediatric limb anomaly center. The study seeks to improve understanding of neuropathic pain after pediatric amputation and its impact on daily functioning.",[65,66,67,68],"Pediatric","Neuropathic Pain","Phantom Limb Pain","Amputation","2026-02-20",{"date":71,"type":72},"2026-02-23","ACTUAL",{"date":74,"type":72},"2026-02-19",{"date":76,"type":61},"2027-02-02",{"name":5,"class":6},1]